3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Brain Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caciagli, F; Ciccarelli, R; D'Alimonte, I; Di Iorio, P; Giuliani, P; Lanuti, P; Nargi, E; Pallini, R; Ricci-Vitiani, L; Zuccarini, M | 1 |
| Choi, HB; McLarnon, JG; Ryu, JK; Wei, W | 1 |
2 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Brain Neoplasms
| Article | Year |
|---|---|
Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.
Topics: Adenosine A3 Receptor Antagonists; Adenosine Triphosphate; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Caspase Inhibitors; Cell Proliferation; Dacarbazine; Drug Synergism; Glioblastoma; Humans; Ligands; Neoplastic Stem Cells; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic; Receptors, Purinergic P1; Receptors, Purinergic P2X7; Temozolomide | 2015 |
Expression and function of the P2X(7) receptor in rat C6 glioma cells.
Topics: Adenosine Triphosphate; Animals; Brain Neoplasms; Calcium; Cell Line, Tumor; Cell Movement; Chemokine CCL2; Gene Expression Regulation, Neoplastic; Glioma; Interleukin-8; Purinergic P2 Receptor Agonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; RNA, Messenger; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A | 2008 |